PMI-002

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePMI-002
Drug Alias NamePMI-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionc-Jun N-terminal kinase stimulantsExtracellular-signal-regulated kinase1 stimulantsP-glycoprotein 1 inhibitors
TargetsExtracellular-signal-regulated kinase1c-Jun N-terminal kinaseP-glycoprotein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPhytomedics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPhytomedics Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A